Takeuchi M, Miyoshi H, Ohshima K
J Clin Exp Hematop. 2021; 61(4):202-209.
PMID: 34937829
PMC: 8808106.
DOI: 10.3960/jslrt.21007.
Taniguchi H, Imaizumi Y, Takasaki Y, Nakashima J, Kato T, Itonaga H
Int J Hematol. 2019; 109(4):402-408.
PMID: 30680667
DOI: 10.1007/s12185-019-02602-4.
Tarokhian H, Rahimi H, Mosavat A, Shirdel A, Rafatpanah H, Akbarin M
BMC Cancer. 2018; 18(1):1287.
PMID: 30577817
PMC: 6303995.
DOI: 10.1186/s12885-018-5209-5.
Ma H, Davarifar A, Amengual J
Curr Hematol Malig Rep. 2018; 13(1):13-24.
PMID: 29397528
DOI: 10.1007/s11899-018-0432-3.
Itonaga H, Sawayama Y, Taguchi J, Honda S, Taniguchi H, Makiyama J
Bone Marrow Transplant. 2015; 50(4):585-91.
PMID: 25621801
DOI: 10.1038/bmt.2014.308.
Microenvironment of adult T-cell leukemia/lymphoma-associated nodal lesions.
Ohshima K, Niino D, Karube K
Int J Hematol. 2014; 99(3):240-8.
PMID: 24481941
DOI: 10.1007/s12185-014-1519-9.
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Kchour G, Rezaee R, Farid R, Ghantous A, Rafatpanah H, Tarhini M
Retrovirology. 2013; 10:91.
PMID: 23962110
PMC: 3751834.
DOI: 10.1186/1742-4690-10-91.
Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
Xie L, Green P
J Virol. 2005; 79(23):14536-45.
PMID: 16282453
PMC: 1287554.
DOI: 10.1128/JVI.79.23.14536-14545.2005.
Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells.
Kohno T, Yamada Y, Akamatsu N, Kamihira S, Imaizumi Y, Tomonaga M
Cancer Sci. 2005; 96(8):527-33.
PMID: 16108835
PMC: 11159675.
DOI: 10.1111/j.1349-7006.2005.00080.x.
Fas gene mutation in the progression of adult T cell leukemia.
Maeda T, Yamada Y, Moriuchi R, Sugahara K, Tsuruda K, Joh T
J Exp Med. 1999; 189(7):1063-71.
PMID: 10190897
PMC: 2193006.
DOI: 10.1084/jem.189.7.1063.
In vivo retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for adult T cell leukemia in a rat model.
Murata K, Fujita M, Yamada Y, Higami Y, Shimokawa I, Tsukasaki K
Jpn J Cancer Res. 1997; 88(5):492-500.
PMID: 9247606
PMC: 5921457.
DOI: 10.1111/j.1349-7006.1997.tb00408.x.
Effect of PHA-activated T cells on B-cell differentiation.
Gansbacher B, Levinson A
Immunology. 1986; 58(2):191-6.
PMID: 3486823
PMC: 1452652.
Adult T-cell leukemia with an unusual phenotype, Leu-2a positive and Leu-3a negative.
Amagasaki T, Tomonaga Y, Yamada Y, Suzuyama J, Ikeda S, Kinoshita K
Blut. 1985; 50(4):209-11.
PMID: 3157413
DOI: 10.1007/BF00320296.
Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.
Yarchoan R, Guo H, Reitz Jr M, Maluish A, Mitsuya H, Broder S
J Clin Invest. 1986; 77(5):1466-73.
PMID: 3009545
PMC: 424547.
DOI: 10.1172/JCI112459.
Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cells.
Miedema F, van Oostveen J, Terpstra F, van den Wall Bake A, Willemze R, Rauws E
J Clin Invest. 1985; 76(6):2139-43.
PMID: 2934407
PMC: 424328.
DOI: 10.1172/JCI112219.
Functional and phenotypic studies of Japanese adult T cell leukemia cells.
Morimoto C, Matsuyama T, Oshige C, Tanaka H, Hercend T, Reinherz E
J Clin Invest. 1985; 75(3):836-43.
PMID: 2858496
PMC: 423612.
DOI: 10.1172/JCI111780.
Adult T-cell leukemia-lymphoma.
Neely S
West J Med. 1989; 150(5):557-61.
PMID: 2662614
PMC: 1026660.
Pleomorphic T-cell leukaemia in a Caucasian adult: clinical phenotypic and functional characteristics.
Hawkey C, Campbell A, Bird G, Gozzard D, Robins R, Toghill P
Postgrad Med J. 1985; 61(715):457-9.
PMID: 2410899
PMC: 2418272.
DOI: 10.1136/pgmj.61.715.457.
